  |
|
|
|---|---|---|
|
|
102: Apoptotische Leukozyten und
deren Sekretionsprodukt. Relevanz für die Herzinfarkttherapie beim
Menschen. ______________________________________________________________________________________ 101: Anti-alpha-Gal antibody titres
remain unaffected by the consumption of fermented milk containing
Lactobacillus casei in healthy adults. ______________________________________________________________________________________ 100: Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Lichtenauer M, Mildner M, Hoetzenecker K, Zimmermann M, Podesser BK, Sipos W, Berényi E, Dworschak D, Tschachler E, Gyöngyösi M, Ankersmit HJ. Basic Research in Cardiology. Abstract ______________________________________________________________________________________ 99: Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Lichtenauer M, Mildner M, Baumgartner A, Hasun M, Werba G, Beer L, Altmann P, Roth G, Gyöngyösi M, Podesser BK, Ankersmit HJ. Basic Res Cardiol. 2011 Jun;106(4):645-55. Abstract ______________________________________________________________________________________ 98: Increased total cytokeratin-18 serum and urine levels in chronic kidney disease.Roth GA, Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Vukovich T, Perne A, Reiter T, Farr A, Hörl WH, Haas M, Krenn CG. Clin Chim Acta. 2011 Apr 11;412(9-10):713-7. Abstract ______________________________________________________________________________________ 97: Research Update: Myocardial lipofuscin-laden lysosomes contain the apoptosis marker caspase-cleaved cytokeratin-18.Lichtenauer M, Ankersmit HJ. Eur J Clin Invest. 2010;40(9):770-789 _________________________________________________________________9_____________________ 96: Impaired recovery of cardiac output and mean arterial pressure after
successful defibrillation in patients with low left ventricular ejection
fraction.
Skhirtladze K, Mora B, Moritz A, Birkenberg B, ______________________________________________________________________________________ 95: Early immunomodulatory effects of linezolid in a human whole blood endotoxin model. Lambers C, Burian B, Binder P, Ankersmit HJ, Wagner C, Müller M, Zeitlinger M. Int J Clin Pharmacol Ther. 2010 Jul;48(7):419-24. Abstract ______________________________________________________________________________________ 94: Considerations on infectious complications using a drowned lung for transplantation. Hoetzenecker K, Ankersmit HJ, Lang G, Scheed A, Marta G, Jaksch P, Klepetko W. Transpl Int. 2010 Jul;23(7):e32-4. Abstract ______________________________________________________________________________________ 93: Spontaneous rupture of the inferior thyroid artery resulting in mediastinal hematoma. Hoetzenecker K, Töpker M, Klepetko W, Ankersmit HJ. Interact Cardiovasc Thorac Surg. 2010 Aug;11(2):209-10. Abstract ______________________________________________________________________________________ 92: Apelin expression in human non-small cell lung cancer: Role in angiogenesis and prognosis. Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Ankersmit HJ, Hegedus B, Renyi-Vamos F, Varga J, Lorincz Z, Paku S, Ostoros G, Rozsas A, Timar J, Dome B. J Thorac Oncol. 2010 Aug;5(8):1120-9. Abstract ______________________________________________________________________________________ 91: Upregulation of Interleukin 33 and soluble ST2 serum levels in liver failure. Roth G, Zimmermann M, Lubsczyk B, Pilz J, Faybik P, Hetz H, Hacker S, Mangold A, Bacher A, Krenn CG, Ankersmit HJ. J Surg Res. 2010 Oct;163(2):e79-83. Abstract ______________________________________________________________________________________ 90: Primary sources and immunological prerequisites for sST2 secretion in humans. Mildner M, Storka A, Lichtenauer M, Mlitz V, Ghannadan M, Hoetzenecker K, Nickl S, Dome B, Tschachler E, Ankersmit HJ. Cardiovasc Res. 2010 Sep 1;87(4):769-77. Abstract ______________________________________________________________________________________ 89: Effect of PBS Solutions on Chemokine Secretion of Human Peripheral Blood Mononuclear Cells. Lichtenauer M, Nickl S, Hoetzenecker K, Mangold A, Mitterbauer A, Hacker S, Zimmermann M, Ankersmit HJ. American Laboratory 2011;43(1):30-33 ______________________________________________________________________________________ 88: Questionable model choice in valve calcification research addressing alpha-Gal. Mangold A, Ankersmit HJ. J Heart Lung Transplant. 2010 Aug;29(8):911-2; discussion 912-3. Epub 2010 Jun 8. Abstract ______________________________________________________________________________________ 87: Reply to the Editor. Ankersmit HJ. Journal of Thoracic and Cardiovascular Surgery 139 (2), pp. 512 ______________________________________________________________________________________ 86: Antivascular agents for non-small-cell lung cancer: current status and future directions. Amir E, Mandoky L, Blackhall F, Thatcher N, Klepetko W, Ankersmit HJ, Reza Hoda MA, Ostoros G, Dank M, Dome B. Expert Opin Investig Drugs. 2009 Nov;18(11):1667-86. ______________________________________________________________________________________ 85: Increased Soluble Serum Markers Caspase-Cleaved Cytokeratin-18, Histones, and ST2 Indicate Apoptotic Turnover and Chronic Immune Response in COPD. Hacker S, Lambers C, Pollreisz A, Hoetzenecker K, M Lichtenauer, Mangold A, Niederpold T, Hacker A, Lang G, Dworschak M, Vukovich T, Gerner C, Klepetko W, Ankersmit HJ. Journal of Clinical Laboratory Analysis (ahead of print) Abstract ______________________________________________________________________________________ 84: Phosphate Buffered Saline Containing Calcium and Magnesium Elicits Increased Secretion of Interleukin-1 Receptor Antagonist. Lichtenauer M,Nickl S, Hoetzenecker K, Mangold A, Moser B, Zimmermann M, Hacker S, Niederpold T, Mitterbauer A, Ankersmit HJ. LabMedicine. 2009; 40, 290-293. Abstract ______________________________________________________________________________________ 83: Abstract ______________________________________________________________________________________ 82: Abstract ______________________________________________________________________________________ 81: Abstract ______________________________________________________________________________________ 80: Abstract ______________________________________________________________________________________ 79: Abstract ______________________________________________________________________________________ 78: Abstract ______________________________________________________________________________________ 77: T-Cell Senescence And Contraction Of T-Cell Repertoire Diversity In Patients With Chronic Obstructive Pulmonary Disease. Lambers C, Hacker S, Posch M, Hoetzenecker K, Pollreisz A, Lichtenauer M, Klepetko W, Ankersmit HJ. Clin Exp Immunol. 2009 Mar;155(3):466-75. Abstract ______________________________________________________________________________________ 76: Alpha-Gal Specific IgG Immune Response after Implantation of Bioprostheses. Mangold A, Hoetzenecker K, Hacker S, Lichtenauer M, Niederpold T, Dworschak, Szerafin T, Auer J, Blumer R, Ankersmit HJ. Thorac Cardiov Surg 2009; 57:191–195. Abstract ______________________________________________________________________________________ 75: Secretion of Soluble ST2 – Possible Explanation for Systemic Immunosuppression after Heart Surgery Szerafin T, Niederpold T, Mangold A, Hoetzenecker K, Hacker S, Roth G, Lichtenauer M, Moser B, Dworschak M, Ankersmit HJ. Thorac Cardiovasc Surg. 2009; 57(1):25-9. Abstract ______________________________________________________________________________________ 74: Cerebral desaturation during cardiac arrest: Its relation to arrest duration and left ventricular pump function. Skhirtladze K, Birkenberg B, Mora B, Moritz A, Ince I, Ankersmit HJ, Steinlechner B, Dworschak M. Crit Care Med. 2008 Dec 26. Abstract ______________________________________________________________________________________ 73: Pro-inflammatory Interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment. Roth GA, Faybik P, Hetz H, Hacker S, Ankersmit HJ, Bacher A, Thalhammer T, Krenn CG. Dig Liver Dis. 2008 Nov 17. Abstract ______________________________________________________________________________________ 72: Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E. Int J Dermatol. 2008 Sep;47(9):918-25. Abstract ______________________________________________________________________________________ 71: An Early Marker of Apoptosis, Caspase-cleaved Cytokeratin-18, is Deposited in Myocardial Lipofuscin. Soleiman A, Lukschal A, Hacker S, Aumayr K, Hoetzenecker K , Lichtenauer M, Untersmeier E, Horvat R and Ankersmit HJ. European journal of clinical investigation 2008 Abstract ______________________________________________________________________________________ 70: Consequences of a wait-and-see Strategy for Benign Metastasizing Leiomyomatosis of the Lung. Hoetzenecker K, Ankersmit HJ, Aigner C, Lichtenauer M, Kreuzer S, Hacker S, Hoetzenecker W, Lang G, Klepetko W. The Annals of Thoracic Surgery 2008. Abstract ______________________________________________________________________________________ Levels of sCD40, sCD40L, TNFα and TNF-RI in the Culprit Coronary Artery During Myocardial Infarction. Hoetzenecker K, Adlbrecht C, Hacker S, Hoetzenecker W, Lichtenauer M, Mangold A, Moser B, Lang G, Lang IM, Muehlbacher F, Klepetko W and Ankersmit HJ. (LabMedicine 2009 - ahead of print) Abstract ______________________________________________________________________________________ 69: ASD Repair after a 10-month treatment with Bosentan in a patient with severe pulmonary arterial hypertension: A Case Report. Hoetzenecker K, Ankersmit HJ, Bonderman D, Hoetzenecker W, Seitelberger R, Klepetko W, Lang IM. Journal of Thoracic and Cardiovascular Surgery. Abstract ______________________________________________________________________________________ 68: Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro. Pollreisz A, Assinger A, Hacker S, Hoetzenecker K, Lang G, Wolfsberger M, Steinlechner B, Bielek E, Lalla E, Klepetko W, Volf I and Ankersmit HJ. Br J Dermatol. 2008 Jun 18. Abstract ______________________________________________________________________________________ 67: Gigantic Coronary Fistula. Ankersmit HJ, Hacker S, Hoetzenecker K, Grimm M. Wien Klin Wochenschr. 2008;120(5-6):152. Abstract ______________________________________________________________________________________ 66: Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Szerafin T, Hoetzenecker K, Hacker S, Horvath A, Pollreisz A, Arpád P, Mangold A, Wliszczak T, Dworschak M, Seitelberger R, Wolner E, Ankersmit HJ. The Annals of Thoracic Surgery 2008 Jan;85(1):80-7. Abstract ______________________________________________________________________________________ 65: Cytomegalovirus hyperimmunoglobulin: mechanisms in allo-immune response in vitro. Hoetzenecker K, Hacker S, Hoetzenecker W, Sadeghi K, Sachet M, Pollreisz A, Mangold A, Wliszczak T, Bielek E, Muehlbacher F, Klepetko W, Ankersmit HJ. European journal of clinical investigation 2007 Dec;37(12):978-86. Abstract ______________________________________________________________________________________ 64: Caspase-cleaved cytokeratin 18 and 20 S proteasome in liver degeneration. Hetz H, Hoetzenecker K, Hacker S, Faybik P, Pollreisz A, Moser B, Roth G, Hoetzenecker W, Lichtenauer M, Klinger M, Krenn CG, Ankersmit HJ; Journal of Clinical Laboratory Analysis 2007 Sep 10;21(5):277-281 Abstract ______________________________________________________________________________________ 63: Elevated levels of interleukin-1beta-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction. Adlbrecht C, Hoetzenecker K, Posch M, Steiner S, Kopp C, Hacker S, Auer J, Horvath R, Moser B, Roth G, Wolner E, Lang IM, Ankersmit HJ; European Journal of Clinical Investigation 2007 May;37(5):372-80. Abstract ______________________________________________________________________________________ 62: Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E; FEMS Microbiology Letters 2007 Jul;272(1):106-13 Abstract ______________________________________________________________________________________ 61: Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Moser B, Szabolcs MJ, Ankersmit HJ, Lu Y, Qu W, Weinberg A, Herold KC, Schmidt AM; American Journal of Transplantation 2007 Feb;7(2):293-302. Abstract ______________________________________________________________________________________ 60: The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. Ankersmit HJ, Hacker S, Hoetzenecker K, Moser B, Wolner E; The Journal of Heart and Lung Transplantation 2006 Nov;25(11):1387-8. Abstract ______________________________________________________________________________________ 59: Invited commentary. Ankersmit HJ, Moser B, Wolner E; The Annals of Thoracic Surgery 2006 Sep;82(3):893-4. Abstract ______________________________________________________________________________________ 58: Neuronal injury after repeated brief cardiac arrests during internal cardioverter defibrillator implantation is associated with deterioration of cognitive function. Weigl M, Moritz A, Steinlechner B, Schmatzer I, Mora B, Fakin R, Zimpfer D, Ankersmit HJ, Khazen C, Dworschak M; Anesthesia and Analgesia 2006 Aug;103(2):403-9. Abstract ______________________________________________________________________________________ 57: Apoptosis-specific activation markers in on- versus off-pump coronary artery bypass graft (CABG) patients. Szerafin T, Horvath A, Moser B, Hacker S, Hoetzenecker K, Steinlechner B, Brunner M, Roth G, Boltz-Nitulescu G, Peterffy A, Wolner E, Ankersmit HJ; Clinical Laboratory 2006;52(5-6):255-61. Abstract ______________________________________________________________________________________ 56: Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Ankersmit HJ, Ullrich R, Moser B, Hoetzenecker K, Hacker S, German P, Krenn C, Horvat R, Grimm M, Wolner E, Zuckermann A; The Thoracic and Cardiovascular Surgeon 2006 Jun;54(4):278-80. Abstract ______________________________________________________________________________________ 55: Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, Fuerst W, Redl H, Roth E, Spittler A; Shock 2006 Feb;25(2):129-34. Abstract ______________________________________________________________________________________ 54: Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions. Szerafin T, Brunner M, Horváth A, Szentgyörgyi L, Moser B, Boltz-Nitulescu G, Péterffy A, Hoetzenecker K, Steinlechner B, Wolner E, Ankersmit HJ; Clinical Laboratory 2005;51(11-12):657-63. Abstract ______________________________________________________________________________________ 53: Endothelin activation and postoperative renal failure after human liver transplantation. Hetz H, Bauer M, Lahner D, Faybik P, Winning J, Ankersmit HJ, Bacher A, Krenn CG; Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005 Oct;11(10):1201-6. Abstract ______________________________________________________________________________________ 52: Heightened levels of circulating 20S proteasome in critically ill patients. Roth GA, Moser B, Krenn C, Roth-Walter F, Hetz H, Richter S, Brunner M, Jensen-Jarolim E, Wolner E, Hoetzenecker K, Boltz-Nitulescu G, Ankersmit HJ; European Journal of Clinical Investigation 2005 Jun;35(6):399-403. Abstract ______________________________________________________________________________________ 51: Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation? Gorlitzer M, Ankersmit J, Fiegl N, Meinhart J, Lanzenberger M, Unal K, Dunkler D, Kilo J, Wolner E, Grimm M, Grabenwoeger M; Transplant International : Official Journal of the European Society for Organ Transplantation 2005 Apr;18(4):390-5. Abstract ______________________________________________________________________________________ 50: Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. Untersmayr E, Bakos N, Schöll I, Kundi M, Roth-Walter F, Szalai K, Riemer AB, Ankersmit HJ, Scheiner O, Boltz-Nitulescu G, Jensen-Jarolim E; The FASEB Journal : Official publication of the Federation of American Societies for Experimental Biology 2005 Apr;19(6):656-8. Abstract ______________________________________________________________________________________ 49: Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B, Boltz-Nitulescu G, Gorlitzer M, Klepetko W, Wolner E, Ankersmit HJ; European Journal of Clinical Investigation 2005 Jan;35(1):17-23. Abstract ______________________________________________________________________________________ 48: Size-reduced lung transplantation: an advanced operative strategy to alleviate donor organ shortage. Aigner C, Winkler G, Jaksch P, Ankersmit J, Marta G, Taghavi S, Wisser W, Klepetko W; Transplantation Proceedings 2004 Nov;36(9):2801-5. Abstract ______________________________________________________________________________________ 47: Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Taghavi S, Zuckermann A, Ankersmit J, Wieselthaler G, Rajek A, Laufer G, Wolner E, Grimm M; The Annals of Thoracic Surgery 2004 Nov;78(5):1644-9. Abstract ______________________________________________________________________________________ 46: Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Roth GA, Zuckermann A, Klepetko W, Wolner E, Ankersmit HJ, Moser B, Volf I; Transplantation 2004 Oct 27;78(8):1238-9. Abstract ______________________________________________________________________________________ 45: CDT values are not influenced by epithelial cell apoptosis in chronic alcoholic patients-preliminary results. Ramskogler K, Brunner M, Hertling I, Dvorak A, Kapusta N, Krenn C, Moser B, Roth G, Lesch OM, Ankersmit HJ, Walter H; Alcoholism, clinical and experimental research 2004 Sep;28(9):1396-8. Abstract ______________________________________________________________________________________ 44: Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Roth GA, Krenn C, Brunner M, Moser B, Ploder M, Spittler A, Pelinka L, Sautner T, Wolner E, Boltz-Nitulescu G, Ankersmit HJ; Shock 2004 Sep;22(3):218-20. Abstract ______________________________________________________________________________________ 43: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients. Bonaros NE, Kocher A, Dunkler D, Grimm M, Zuckermann A, Ankersmit J, Ehrlich M, Wolner E, Laufer G; Transplantation 2004 Mar 27;77(6):890-7. Abstract ______________________________________________________________________________________ 42: Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Brunner M, Krenn C, Roth G, Moser B, Dworschak M, Jensen-Jarolim E, Spittler A, Sautner T, Bonaros N, Wolner E, Boltz-Nitulescu G, Ankersmit HJ; Intensive Care Medicine 2004 Jul;30(7):1468-73. Abstract ______________________________________________________________________________________ 41: Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina. Ankersmit HJ, Weber T, Auer J, Roth G, Brunner M, Kvas E, Moser B, Spreitzer S, Lassnig E, Maurer E, Hartl P, Wolner E, Boltz-Nitulescu G, Eber B; Heart 2004 Feb;90(2):151-4. Abstract ______________________________________________________________________________________ 40: A retrospective analysis of extracorporel membrane oxygenation versus right ventricular assist device in acute great failure after heart transplantation. Taghavi S, Ankersmit J, Zuckermann A, Roth GA, Wieselthaler G, Rajek A, Wolner E, Grimm M; Transplantation Proceedings 2003 Nov;35(7):2805-7. Abstract ______________________________________________________________________________________ 39: Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Roth G, Moser B, Krenn C, Brunner M, Haisjackl M, Almer G, Gerlitz S, Wolner E, Boltz-Nitulescu G, Ankersmit HJ; Biochemical and Biophysical Research Communications 2003 Sep 5;308(4):840-6. Abstract ______________________________________________________________________________________ 38: Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Moser B, Roth G, Brunner M, Lilaj T, Deicher R, Wolner E, Kovarik J, Boltz-Nitulescu G, Vychytil A, Ankersmit HJ; Biochemical and Biophysical Research Communications 2003 Aug 29;308(3):581-5. Abstract ______________________________________________________________________________________ 37: Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation. Zuckermann A, Dunkler D, Deviatko E, Bodhjalian A, Czerny M, Ankersmit J, Wolner E, Grimm M; European Journal of Cardio-thoracic Surgery 2003 Aug;24(2):283-91. Abstract ______________________________________________________________________________________ 36: Immunobiologic consequences of assist devices. Itescu S, Schuster M, Burke E, Ankersmit J, Kocher A, Deng M, John R, Lietz K; Cardiology Clinics 2003 Feb;21(1):119-33. Abstract ______________________________________________________________________________________ 35: CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia. Ankersmit HJ, Roth GA, Moser B, Zuckermann A, Brunner M, Rosin C, Buchta C, Bielek E, Schmid W, Jensen-Jarolim E, Wolner E, Boltz-Nitulescu G, Volf I; American Journal of Transplantation 2003 Jun;3(6):754-9. Abstract ______________________________________________________________________________________ 34: Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Ankersmit HJ, Roth G, Zuckermann A, Moser B, Obermaier R, Taghavi S, Brunner M, Wieselthaler G, Lanzenberger M, Ullrich R, Laufer G, Grimm M, Wolner E; American Journal of Transplantation 2003 Feb;3(2):231-4. Abstract ______________________________________________________________________________________ 33: Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients. Lietz K, John R, Schuster M, Ankersmit J, Burke E, Suciu-Foca N, Edwards N, Mancini D, Itescu S; Transplantation Proceedings 2002 Aug;34(5):1828-9. Abstract ______________________________________________________________________________________ 32: Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Ankersmit HJ, Moser B, Zuckermann A, Roth G, Taghavi S, Brunner M, Wolner E, Boltz-Nitulescu G; Clinical and Experimental Immunology 2002 Apr;128(1):175-80. Abstract ______________________________________________________________________________________ 31: Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump. Ankersmit HJ, Wieselthaler G, Moser B, Gerlitz S, Roth G, Boltz-Nitulescu G, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 2002 Mar;123(3):557-61. Abstract ______________________________________________________________________________________ 30: Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy. Ankersmit HJ, Moser B, Roedler S, Teufel I, Zuckermann A, Roth G, Lietz K, Back C, Gerlitz S, Wolner E, Boltz-Nitulescu G; Clinical and Experimental Immunology 2002 Jan;127(1):183-9. Abstract ______________________________________________________________________________________ 29: B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Schuster M, Kocher A, John R, Hoffman M, Ankersmit J, Lietz K, Edwards N, Oz M, Itescu S; Human Immunology 2002 Mar;63(3):211-20. Abstract ______________________________________________________________________________________ 28: Backtable ventricular and atrial septal defect repair of an Eisenmenger allograft with concomitant domino heart transplantation. Gorlitzer M, Ankersmit HJ, Wollenek G, Wisser W, Wieselthaler G, Haisjackl M, Horvat R, Gabriel H, Wolner E, Grimm M; The Journal of Thoracic and Cardiovascular Surgery 2002 Feb;123(2):374-6. Abstract ______________________________________________________________________________________ 27: Extracorporeal membrane oxygenation for graft failure after heart transplantation: recent Vienna experience. Taghavi S, Ankersmit HJ, Wieselthaler G, Gorlitzer M, Rajek A, Wolner E, Grimm M; The Journal of Thoracic and Cardiovascular Surgery 2001 Oct;122(4):819-20. Abstract ______________________________________________________________________________________ 26: Aberrant T-cell activation via CD95 and apoptosis in peripheral T lymphocytes in stable heart transplant recipients. Ankersmit HJ, Moser B, Hoffman M, Kocher AA, Schlechta B, Boltz-Nitulescu G, Wolner E; Transplantation Proceedings 2001 Aug;33(5):2860-1. Abstract ______________________________________________________________________________________ 25: Outcome of pediatric heart transplantation: an analysis of 27 cases. Schlechta B, Kocher AA, Ehrlich M, Ankersmit J, Ploner M, Walch K, Nourani F, Czerny M, Wolner E, Wollenek G, Grimm M; Transplantation Proceedings 2001 Aug;33(5):2834-5. Abstract ______________________________________________________________________________________ 24: Heart retransplantation: institutional results of a series of 31 cases. Schlechta B, Kocher AA, Ehrlich M, Ankersmit J, Ploner M, Walch K, Nourani F, Czerny M, Wolner E, Grimm M; Transplantation Proceedings Aug;33(5):2759-61. Abstract ______________________________________________________________________________________ 23: Etiology of pulmonary nodules after heart transplantation. Kocher AA, Funovics M, Khazen C, Ploner M, Ehrlich M, Schlechta B, Nourani F, Ankersmit J, Wolner E, Laufer G; Transplantation Proceedings 2001 Aug;33(5):2757-8. Abstract ______________________________________________________________________________________ 22: Effect of ABO blood type matching in cardiac transplant recipients. Kocher AA, Schlechta B, Ehrlich M, Ploner M, Khazen C, Schuster MP, Ankersmit J, Grimm M, Wolner E, Laufer G, Lassnigg A, Bonaros N; Transplantation Proceedings 2001 Aug;33(5):2752-4. Abstract ______________________________________________________________________________________ 21: Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Lietz K, John R, Burke EA, Ankersmit JH, McCue JD, Naka Y, Oz MC, Mancini DM, Edwards NM; Transplantation 2001 Jul 27;72(2):277-83. Abstract ______________________________________________________________________________________ 20: Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Ankersmit HJ, Deicher R, Moser B, Teufel I, Roth G, Gerlitz S, Itescu S, Wolner E, Boltz-Nitulescu G, Kovarik J; Clinical and Experimental Immunology 2001 Jul;125(1):142-8. Abstract ______________________________________________________________________________________ 19: De novo inverted left atrial appendage: an unrecognized cause of left atrial mass with symptoms mimicking myxoma. Ankersmit HJ, Mohl W, Moser B, Kocher A, Ehrlich M, Grimm M, Horvat R, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 2001 Jun;121(6):1211-3. Abstract ______________________________________________________________________________________ 18: Automated implantable cardiac defibrillator and biventricular Thoratec assist device as bridge to transplantation in a patient with sarcoidosis. Ankersmit HJ, Wieselthaler GA, Moser B, Taghavi S, Grimm M, Roth G, Gorlitzer M, Tschernich H, Horvat R, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 2001 Jun;121(6):1198-9. Abstract ______________________________________________________________________________________ 17: Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface. Schuster M, Kocher A, Lietz K, Ankersmit J, John R, Edwards N, Oz M, Itescu S; Transplantation Proceedings 2001 Feb-Mar;33(1-2):1960-1. Abstract ______________________________________________________________________________________ 16: Induction of T-cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependent on calcineurin activation. Schuster M, Ankersmit J, Kocher A, Lietz K, Schuster N, Hofmann M, John R, Edwards N, Oz M, Itescu S; Transplantation Proceedings 2001 Feb-Mar;33(1-2):1958-9. Abstract ______________________________________________________________________________________ 15: Increased death inducing receptors in vivo and activation-induced T-cell death by anti-thymocyte antibody treatment of stable cardiac transplant recipients. Ankersmit H, Moser B, Teufel I, Hericis R, Grimm M, Boltz-Nitulescu G, Wolner EP; The Journal of Heart and Lung Transplantation 2001 Feb;20(2):187. Abstract ______________________________________________________________________________________ 14: Immunobiology of left ventricular assist devices. Itescu S, Ankersmit JH, Kocher AA, Schuster MD; Progress in Cardiovascular Diseases 2000 Jul-Aug;43(1):67-80. Abstract ______________________________________________________________________________________ 13: Inverted left atrial appendage masquerading as myxoma. Ankersmit HJ, Kocher A, Frank H, Mohl W, Wolner E; Circulation 2000 Jan 25;101(3):E42-3. Abstract ______________________________________________________________________________________ 12: Effect of obesity on outcome after cardiac transplantation. Kocher AA, Ankersmit J, Khazen C, Ofner P, Zuckermann A, Grimm M, Schlechta B, Ehrlich M, Wolner E, Laufer G; Transplantation Proceedings 1999 Dec;31(8):3187-9. Abstract ______________________________________________________________________________________ 11: Modified technique of delivering solutions to rat coronary arteries in the transplant setting. Nourani F, Laufer G, Hollensteiner H, Bergmeister H, Buschle M, Khazen C, Ankersmit J, Traxler H, Wolner E, Losert U, Kocher AA; Transplantation Proceedings 1999 Dec;31(8):3255-6. Abstract ______________________________________________________________________________________ 10: Repair of an aortic aneurysm at the time of heart transplantation: report of two cases and review of the literature. Kocher A, Ehrlich M, Khazen C, Ankersmit J, Nourani F, Itescu S, Edwards NM, Wolner E, Laufer G; Transplantation Proceedings 1999 Dec;31(8):3184-6. Abstract ______________________________________________________________________________________ 9: Midterm results after combined heart and kidney transplantation. Kocher AA, Khazen C, Ankersmit J, Ofner P, Schlechta B, Ehrlich M, Wolner E, Laufer G; Transplantation Proceedings 1999 Dec;31(8):3181-3. Abstract ______________________________________________________________________________________ 8: Impact of retrograde cerebral perfusion on aortic arch aneurysm repair. Ehrlich MP, Fang WC, Grabenwöger M, Kocher A, Ankersmit J, Laufer G, Grubhofer G, Havel M, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 1999 Dec;118(6):1026-32. Abstract ______________________________________________________________________________________ 7: Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. John R, Lietz K, Burke E, Ankersmit J, Mancini D, Suciu-Foca N, Edwards N, Rose E, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II229-35. Abstract ______________________________________________________________________________________ 6: Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Ankersmit HJ, Edwards NM, Schuster M, John R, Kocher A, Rose EA, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II211-5. Abstract ______________________________________________________________________________________ 5: Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, Flannery M, Mancini D, Rose EA, Edwards NM, Oz MC, Itescu S; Lancet 1999 Aug 14;354(9178):550-5. Abstract ______________________________________________________________________________________ 4: Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1, 2)-fucosyltransferase. Artrip JH, Kwiatkowski P, Michler RE, Wang SF, Tugulea S, Ankersmit J, Chisholm L, McKenzie IF, Sandrin MS, Itescu S; The Journal of Biological Chemistry 1999 Apr 16;274(16):10717-22. Abstract ______________________________________________________________________________________ 3: Combined heart and kidney transplantation using a single donor: a single center's experience with nine cases. Kocher AA, Schlechta B, Kopp CW, Ehrlich M, Ankersmit J, Ofner P, Langer F, Berlakovich GA, Grimm M, Wolner E, Laufer G; Transplantation 1998 Dec 27;66(12):1760-3. Abstract ______________________________________________________________________________________ 2: Importance of CD49d-VCAM interactions in human monocyte adhesion to porcine endothelium. Kwiatkowski P, Artrip JH, Ankersmit J, Schuster M, John R, Wang SF, Ma N, Michler RE, Itescu S; Xenotransplantation 1998 Feb;5(1):67-74. Abstract ______________________________________________________________________________________ 1: Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Itescu S, Kwiatkowski P, Artrip JH, Wang SF, Ankersmit J, Minanov OP, Michler RE; Human immunology 1998 May;59(5):275-86. Abstract ______________________________________________________________________________________
|
